British American Tobacco p.l.c. (BATS.L) Stock Analysis
A cash-rich tobacco incumbent, structurally re-rated too cheaply, is funding a credible smokeless pivot with pricing power, buybacks, and an undervalued ITC stake as the hidden backstop.
Overview
British American Tobacco (BATS.L) is an oligopolistic global nicotine consumer staples company executing a long, capital-intensive shift from combustibles to reduced-risk “New Categories.” The legacy cigarette portfolio (Dunhill, Lucky Strike, Pall Mall, Kent, Rothmans) remains the profit foundation, with price/mix actions engineered to offset structural volume declines and fund innovation. In 2025 BAT reported £25.61bn revenue; on a constant-currency basis revenue grew 2.1% despite a 3.1% FX translation headwind. New Categories (Vuse vapor, glo heated tobacco, Velo oral pouches) are now 18.2% of revenue (~£3.62bn) and reached 34.1m regular smokeless consumers (+4.7m YoY), with targets of 50m by 2030 and 50% revenue mix by 2035. The US remains the profit epicenter and returned to growth in 2025, supported by combustible stabilization and rapid Velo Plus scaling. BAT is best framed as a high-cash-flow compounder balancing terminal combustibles with a now-profitable smokeless ramp, while maintaining dividends, buybacks, and deleveraging discipline.